Clinical trial · Interventional
Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
A Pilot Study of Single-Port Robot-Assisted Surgery Using Da Vinci SP Surgical System for Patients With Upper Tract Urothelial Cancer
NCT06987552CI-TRIAL-00090126recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate patient-reported outcomes of radical nephroureterectomy using single-port robotic surgery
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Upper Tract Urothelial Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Da Vinci SP Surgical System | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Operation of focus procedure with da Vinci SP Surgery System
- description
- Single-Port Robot-Assisted Surgery Using Da Vinci SP Surgical System for Patients with Upper Tract Urothelial Cancer
- interventionNames
- Device: Da Vinci SP Surgical System
Primary outcomes (1)
- measure
- Incidence of conversion rate
- timeFrame
- During Surgery
- description
- The primary performance endpoint will be assessed as the ability to successfully completed the planned procedure with da Vinci SP System, with no conversion to alternative surgery including open surgery or laparoscopy.
Secondary outcomes (10)
- measure
- Perioperative Parameters: Operative Time
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * Age 20 years or more * Histologically or cytologically diagnosed upper tract urothelial cancer * Fitting indications of radical nephroureterectomy and ipsilateral bladder cuff resection, and deemed feasible for robotic surgery * ASA physical status classification 1-2 and adequate organ function * Patients willing and able to comply with study protocol requirements and follow-up * With informed consent Exclusion Criteria: * Synchronous bladder cancer * Distant metastasis of cancer * BMI ≥30 or BMI \<18.5 * Unable to tolerate lateral decubitus or Trendelenburg position (relative contra-indication) * Severe adhesion due to prior abdominopelvic surgery (relative contra-indication) * Previous radiation treatment to the pelvic area * Active infectious disease * Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions, such as: severe heart disease (NYHA functional class III-IV) or severe lung disease (GOLD Group C-D) * Cannot follow trial-required procedures * Concomitant systemic or pelvic disease that increases the risk of surgery * Long-term use of anti-coagulant(s) * Patients with coagulopathy * Emergency surgery
References
Publications (0)
Data not yet available
No reference posted for this study.